Benzodiazepines and drugs with strong anticholinergic effects have been linked to Alzheimer’s disease in people who take them. Higher doses and longer use were associated with higher risk. There are several alternatives to both types.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.